MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, AVTX has $116,458K in assets. $33,409K in debts. $15,858K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
813.65%
Quick Ratio
813.65%
Cash Ratio
122.55%
Debt to Asset Ratio
28.69%
Unit: Thousand (K) dollars
Assets Breakdown
    • Short-term investments
    • Cash and cash equivalents
    • Goodwill
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Derivative liability, non-curren...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
15,858
Short-term investments
82,478
Prepaid expenses and other current assets
6,913
Restricted cash, current portion
37
Total current assets
105,286
Property and equipment, net
460
Goodwill
10,502
Restricted cash, net of current portion
210
Total assets
116,458
Accounts payable
137
Accrued expenses and other current liabilities
12,803
Derivative liability, current
0
Total current liabilities
12,940
Royalty obligation
2,000
Deferred tax liability, net
434
Derivative liability, non-current
18,000
Other long-term liabilities
35
Total liabilities
33,409
Temporary equity, values issued-Series DPreferred Stock
0
Temporary equity, values issued-Series EPreferred Stock
0
Common stock0.001 par value 200,000,000 shares authorized at december31, 2025 and december31, 2024 18,512,757 and 10,471,934 shares issued and outstanding at december31, 2025 and december31, 2024, respectively
18
Additional paid-in capital
531,485
Accumulated other comprehensive income
68
Accumulated deficit
-448,522
Total stockholders equity
83,049
Total liabilities, mezzanine equity and stockholders equity
116,458
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Short-term investments$82,478K Cash and cashequivalents$15,858K Prepaid expenses andother current assets$6,913K Restricted cash, currentportion$37K Total current assets$105,286K Goodwill$10,502K Property and equipment,net$460K Restricted cash, net ofcurrent portion$210K Total assets$116,458K Total liabilities,mezzanine equity and...$116,458K Total stockholdersequity$83,049K Total liabilities$33,409K Accumulated deficit-$448,522K Additional paid-in capital$531,485K Derivative liability,non-current$18,000K Total currentliabilities$12,940K Royalty obligation$2,000K Deferred tax liability,net$434K Other long-termliabilities$35K Accumulated othercomprehensive income$68K Common stock0.001 parvalue 200,000,000...$18K Accrued expenses andother current...$12,803K Accounts payable$137K

Avalo Therapeutics, Inc. (AVTX)

Avalo Therapeutics, Inc. (AVTX)